Need great candidates fast?.Our community is full of field reps, managers & insiders. 📢 Post your listing today: #MedicalSalesJobs #Recruiting.

New on CP Wire: Alfa Chemistry Launches Bulk Chemicals Portfolio to Support New Developments in Pharmaceuticals, Agriculture, and Industry.

Join millions who have switched to Grok.

Thurs news: Novo in RNA drug deal with startup Replicate. Virginia to offer manufacturing packages to AZ and Lilly. Merck-Daiichi breast cancer trial. First-ever generic weight loss drug approved. FDA’s narrowed COVID booster approval. —

Wed news: Pharma spending in China. Startup Wugen raises $115M for CAR-T. Lilly’s Verzenio breast cancer win. GLP-1s good for the environment, too. Sandoz CEO on navigating tariffs. —

Tue news: Lilly weight loss pill clears latest trial. Terumo buying OrganOx. Will COVID vaccines be banned? Roche US manufacturing facility. MannKind grabs scPharmaceuticals. —

New on CP Wire:. Top 15 Pharmaceutical Companies for Salespeople in 2025 - @repvue

Mon news: AbbVie buying Gilgamesh psychedelic drug. Finally, another biotech IPO. Medtech topics to watch for the rest of ’25. FDA suspends Valneva chikungunya vaccine. FDA’s new accelerated pathway. —

Thurs news: Kite Pharma to buy cell therapy company. Takeda looks to India for global clinical trials. Dynavax soars on shingles vaccine trial. Sarepta pushes off debt payments. CVS Health won’t cover new Gilead PrEP. —

New on CP Wire:.Top 20 Medical Device Companies for Salespeople in 2025 Any surprises for you on this list?.@repvue

Wed news: Novo Nordisk freezes hiring in some business areas. Lilly searches for new near chief. Jazz Pharma buys new epilepsy prospect. DTC pharma advertising may come under fire. Pharma Q2 earnings turnaround. —

Tue news: Amgen’s ChemoCentryx prevails in investor lawsuit. Experts warns on Kennedy’s mRNA cuts. Canada approves Ozempic to reduce kidney damage in diabetics. Medtronic posts growth. Novartis taps Atropos AI for earlier PNH diagnoses. —

Mon news: Biopharma layoffs rise. Vanda touts landmark win over FDA. AstraZeneca’s at-home flu vaccine. Novo cuts GLP-1 prices for cash buyers. Novo wins MASH approval for Wegovy. —

Fri news: Pfizer sickle cell drug fails trial. Amgen skirts patent litigation payout. Lundbeck dials up migraine drug sales estimate. Lilly endorses Trump’s drug pricing goal. FDA clears Precigen's rare tumor immunotherapy —

Thurs news: Blood oxygen monitoring on Apple Watches. Novo’s Wegovy launches in South Africa. Lilly hikes UK price for Mounjaro. Superluminal $1.3B drug development pact with Lilly. Pharma tariffs reportedly not imminent. —

Wed news: Merck begins 8% workforce purge. Lilly launches Mounjaro pen in India. Novo’s rapid rise and fall. Puerto Rico and biotech innovation. FDA tolerated contaminated drug shipments from Sun Pharma. —

Tue news: Obesity leaders dig manufacturing moats. Another phase 3 win for Novartis drug. Cardinal Health buying Solaris. Pfizer-Astellas bladder cancer drug trial success. AI and biotech bill package. —

Mon news: Novartis Sjögren’s trial success. Where is Hims & Hers in the Novo Wegovy legal battle? 5 oral challengers to Lilly’s orforglipron. Swiss government/pharma tariff meeting. Boehringer lung cancer approval. —

Fri news: Could Basel be the next big biotech hub? GSK and CureVac settle patent spat with Pfizer. AbbVie’s Skyrizi has top TV ad impressions. Iovance cuts staff. Gilead posts Q2 beat. —

Thurs news: Lilly oral weight loss drug underdelivers. Merck had no competition for Verona. FDA announces program to boost US drug manufacturing. AZ’s lung cancer strategy. FTC challenges Edwards’ acquisition. —

Wed news: Novo warns of job cuts. Alcon acquiring STAAR Surgical. Bayer expects more layoffs. RFK Jr. pulls federal vaccine funding. Pfizer CEO says US biotech needs federal support to match China. —

Tue news: Strong quarterly results for Pfizer. July layoffs skyrocket 487% YOY. Trump says pharma tariffs may eventually be 250%. Corcym aortic valve robotically implanted. Vertex drops aspiring Journavx follower. —